Mehmet Turker

Adana, 01260, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Remarkable Response to Pembrolizumab in Metastatic Cancer of Unknown Primary.

Remarkable Response to Pembrolizumab in Metastatic Cancer of Unknown Primary.

Journal: Clinical laboratory
Published: September 04, 2026

Quantitative Immunohistochemical Landscapes and Chemoimmunotherapy Outcomes of ASCL1, NEUROD1, POU2F3, and YAP1 in Pure Small-Cell Lung Cancer: A Pilot Study.

Quantitative Immunohistochemical Landscapes and Chemoimmunotherapy Outcomes of ASCL1, NEUROD1, POU2F3, and YAP1 in Pure Small-Cell Lung Cancer: A Pilot Study.

Journal: Journal of clinical medicine
Published: July 19, 2026

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Journal: Cancers
Published: June 09, 2026

First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score.

First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score.

Journal: Medicina (Kaunas, Lithuania)
Published: June 01, 2026

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

Journal: Journal of clinical medicine
Published: May 28, 2026

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors.

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors.

Journal: Journal of clinical medicine
Published: April 02, 2026

Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study.

Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study.

Journal: BMC cancer
Published: November 04, 2025

Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI.

Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI.

Journal: Biomarkers in medicine
Published: September 13, 2025

Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer.

Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer.

Journal: Clinical laboratory
Published: August 08, 2025

Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma.

Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma.

Journal: American journal of therapeutics
Published: April 11, 2025

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Journal: Scientific reports
Published: March 19, 2025

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Journal: Scientific reports
Published: May 18, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026